ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="sammmy" data-source="post: 271888" data-attributes="member: 38594"><p>A Phase II study for BPC-157 in the form of enemas for Inflammatory Bowel Disease was started in 2002 and again radio silence after that, no results published, no phase III study initiated, which means they did not like the result or have safety concerns:</p><p></p><p>[URL unfurl="true"]https://www.croris.hr/crosbi/publikacija/prilog-skup/506120[/URL]</p><p></p><p>This is rather sketchy and doesn't inspire confidence in the main claim behind BPC-157 that it is protective in the gastro intestinal tract. You don't prove a drug safety and effectiveness by just doing trials and not publishing anything after that. It does sound fancy to the "labrats" that it is in trial, but not after 20 years have passed and there are no results. You don't find an effective drug for IBD or Colitis and sit on it for 2 decades ...</p></blockquote><p></p>
[QUOTE="sammmy, post: 271888, member: 38594"] A Phase II study for BPC-157 in the form of enemas for Inflammatory Bowel Disease was started in 2002 and again radio silence after that, no results published, no phase III study initiated, which means they did not like the result or have safety concerns: [URL unfurl="true"]https://www.croris.hr/crosbi/publikacija/prilog-skup/506120[/URL] This is rather sketchy and doesn't inspire confidence in the main claim behind BPC-157 that it is protective in the gastro intestinal tract. You don't prove a drug safety and effectiveness by just doing trials and not publishing anything after that. It does sound fancy to the "labrats" that it is in trial, but not after 20 years have passed and there are no results. You don't find an effective drug for IBD or Colitis and sit on it for 2 decades ... [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
A human trial of oral BPC-157 was quickly canceled
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top